000 03887cam a2200457Ia 4500
001 vtls003240872
003 MY-SjTCS
005 20200508124542.0
006 m d
007 cr cnu---unuuu
008 120913s2008 nyua sb 001 0 eng d
020 _a9781420070439 (ebk.)
020 _a1420070436 (ebk.)
020 _a9786611948726
020 _a6611948724
020 _z1420070428 (Cloth)
020 _z9781420070422
035 _a(OCoLC)312146716
035 _a(OCoLC)ocn312146716
039 9 _a201209131004
_bshuhada
_y201209131002
_zshuhada
043 _an-us---
082 0 4 _a344.7304/233
_222
245 0 4 _aThe pharmaceutical regulatory process
_h[electronic resource] /
_cedited by Ira R. Berry, Robert P. Martin.
250 _a2nd ed.
260 _aNew York :
_bInforma Healthcare,
_cc2008.
300 _a1 online resource (x, 469 p.) :
_bill.
490 1 _aDrugs and the pharmaceutical sciences ;
_v185
504 _aIncludes bibliographical references and index.
505 0 _aPharmaceutical regulation before and after the Food, Drug, and Cosmetic Act / John P. Swann -- Modernizing the Food And Drug Administration / Arthur Y. Tsien -- The new drug-approval process : before and after 1962 / Michael P. Peskoe -- Generic drug approval process : Hatch-Waxman Update / Marc S. Gross ... [et al.] -- FDA regulation of biological products / Michael S. Labson, Krista Hessler Carver, and Marie C. Boyd -- FDA's antibiotic regulatory scheme : then and now / Irving L. Wiesen -- Generic drugs in a changing intellectual property landscape / Neil F. Greenblum ... [et al.] -- The influence of the Prescription Drug User Fee Act on the approval process / Marc J. Scheineson.
505 0 _aClinical research requirements for new drug applications / Gary L. Yingling and Ann M. Begley -- Postapproval marketing practices regarding drug safety and pharmacovigilance / Robert P. Martin -- Drugs marketed without FDA approval / Jane Baluss and David Rosen -- FDA regulation of foreign drug imports : the need for improvement / Benjamin L. England -- Active pharmaceutical ingredients / Max S. Lazar -- Obtaining approval of New Drug Applications and Abbreviated New Drug Applications from a chemistry, manufacturing, and controls perspective / Dhiren N. Shah -- Obtaining approval of a generic drug : pre- 1984 to the present / Loren Gelber -- New developments in the approval and marketing of nonprescription or OTC drugs / William J. Mead.
505 0 _aCurrent good manufacturing practice and the drug approval process / Ira R. Berry -- The influence of the USP on the drug approval process / Edward M. Cohen -- Ways, means, and evolving trends in the U.S. registration of drug products from foreign countries / Alberto Grignolo -- Impact of government regulation on prescription drug marketing and promotion / Daniel Glassman, Gene Goldberg, and Barbara Spallitta -- CMC postapproval regulatory affairs : constantly managing change / Leo J. Lucisano, Kevin A. Miller, and Lorien Armour -- Living with 21 CFR part 11 compliance / Richard L. Burcham.
588 _aDescription based on print version record.
650 0 _aPharmacy
_xLaw and legislation
_zUnited States.
_921087
650 0 _aDrugs
_xLaw and legislation
_zUnited States.
_921088
650 0 _aElectronic books.
700 1 _aBerry, Ira R.,
_d1942-
_921089
700 1 _aMartin, Robert P.
_q(Robert Paul)
_964571
776 0 8 _iPrint version:
_tPharmaceutical regulatory process.
_b2nd ed.
_dNew York : Informa Healthcare, c2008
_z9781420070422
_z1420070428
_w(DLC) 2008042661
_w(OCoLC)259902129
830 0 _aDrugs and the pharmaceutical sciences ;
_vv. 185.
_921072
856 4 0 _uhttps://ezproxy.taylors.edu.my/login?url=http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=260345
_zAn electronic book accessible through the World Wide Web; click to view
999 _c145243
_d145243